International Isotopes And RadQual LLC Complete A New, Exclusive, Long Term Contract Manufacturing Agreement

IDAHO FALLS, Idaho, Jan. 18 /PRNewswire-FirstCall/ -- International Isotopes Inc. announces the completion of a new, exclusive, long-term contract manufacturing agreement of Benchmark(TM) products for RadQual LLC, Concord, New Hampshire.

International Isotopes Inc. has been providing contract manufacturing services for RadQual under an agreement that was originally entered into in 2001. Under the new agreement, the companies will continue their contract manufacturing relationship on a long-term basis without any specific future termination date. Under this agreement, International Isotopes will continue to manufacture a wide range of Benchmark(TM) nuclear medicine calibration and reference standards exclusively for RadQual. International Isotopes annual sales to RadQual have grown at an average rate of approximately 20% per year since 2001.

Steve T. Laflin, President and CEO of International Isotopes, said, “The Company has enjoyed and continues to benefited from its contract manufacturing relationship with RadQual and I am very pleased to have an opportunity to continue this relationship. RadQual’s technical expertise, distributor relationships, and excellent customer service philosophies have served to continually increase their sales and market share in a very competitive industry.”

Keith Allberg, President of RadQual said, “The outstanding commitment, technical knowledge and flexibility of the team employed at International Isotopes to meet RadQual’s distributors demands made this an easy decision. We couldn’t ask for anything more from a manufacturing organization and look forward to continued growth of our existing products and introduction of our new products in 2006.”

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, manufactures high purity fluoride gases and a range of cobalt-60 products such as teletherapy sources, high purity fluoride gasses, and provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications. The company also provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.

International Isotopes Inc. Safe Harbor Statement

Forward-looking statements in this press release relating to International Isotopes contract manufacturing, potential market growth, and revenue expectations and its ongoing relationship with RadQual are made pursuant to the safe harbor provision of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change. Actual results may differ materially from the forward- looking statements. Many factors could cause actual results to differ materially from the forward-looking statements. Readers are directed to read the risk factors detailed from time to time in our filings with the Securities and Exchange Commission, including our annual report on Form 10-KSB for the year ended December 31, 2004.

For More Information, Contact:

Steve Laflin, President and CEO

(208) 524-5300

International Isotopes Inc.

CONTACT: Steve Laflin, President and CEO of International Isotopes Inc.,+1-208-524-5300

MORE ON THIS TOPIC